# Phio Pharmaceuticals Corp.: Form 8-K, filed Aug 10, 2023

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2023-08-10
- Accepted by EDGAR: Aug 10, 2023, 16:40 ET
- Period: 2023-08-10
- Accession: 0001683168-23-005515
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316823005515/phio_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316823005515/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316823005515/phio_8k.htm

Filed Aug 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001683168-23-005515. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
